MUSTANG BIO, INC. Payments of Debt Issuance Costs
MUSTANG BIO, INC. (MBIO) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2024-03-11
- MUSTANG BIO, INC. payments of debt issuance costs for the quarter ending 2023-12-31 was $0.00.
- MUSTANG BIO, INC. payments of debt issuance costs for the quarter ending 2023-09-30 was $0.00.
- MUSTANG BIO, INC. payments of debt issuance costs for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. payments of debt issuance costs for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. payments of debt issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- MUSTANG BIO, INC. payments of debt issuance costs for fiscal 2022 was $2.65M.
- MUSTANG BIO, INC. payments of debt issuance costs for fiscal 2021 was $0.00.
- MUSTANG BIO, INC. payments of debt issuance costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments of Debt Issuance Costs | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $0.00 derived: sum of 2 quarters · filed 2024-03-11 | $0.00 derived: sum of 3 quarters · filed 2024-03-11 | $0.00 10-K · filed 2024-03-11 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-03-11 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-11 | -$1.00K derived: sum of 4 quarters · filed 2024-03-11 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2024-03-11 | -$1.00K derived: sum of 3 quarters · filed 2024-03-11 | $16.00K derived: sum of 4 quarters · filed 2024-03-11 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$1.00K derived: sum of 2 quarters · filed 2024-03-11 | $16.00K derived: sum of 3 quarters · filed 2024-03-11 | $2.65M 10-K · filed 2024-03-11 | |
| 2022-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $16.00K derived: sum of 2 quarters · filed 2023-11-14 | $2.65M 10-Q · filed 2023-11-14 | $2.65M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.65M 10-Q · filed 2023-08-14 | $2.65M derived: sum of 3 quarters · filed 2023-08-14 | $2.65M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $2.63M 10-Q · filed 2023-05-12 | $2.63M derived: sum of 2 quarters · filed 2023-05-12 | $2.63M derived: sum of 3 quarters · filed 2023-05-12 | $2.63M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2022-03-04 | $400.00K 10-K · filed 2023-03-30 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $0.00 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-08-11 | $0.00 derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-05-12 | $0.00 derived: sum of 3 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $0.00 derived: sum of 2 quarters · filed 2021-03-24 | $0.00 10-K · filed 2021-03-24 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $163.00K derived: sum of 2 quarters · filed 2021-03-24 | $1.39M 10-K · filed 2021-03-24 | ||
| 2019-09-30 | $163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.39M 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $1.23M 10-Q · filed 2020-08-10 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 10-K · filed 2020-03-16 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | ||||
| 2016-09-30 | $129.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |